Given that TGF-β1 can utilise various programmes to promote cancer metastasis through its effects on the tumour microenvironment, enhanced invasive properties, and inhibition of immune cell function, our findings also reveal that FOSL2 may increase invasive potential through the TGF-β pathway. The gene discussed is TGFB1; the disease is neoplasm.